SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 18 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Bizumentary to Premiere Sept. 24 Across National Networks
Beeline Holdings (NASDAQ: BLNE) announced that its “Bizumentary,” produced in partnership with Emmy Award-winning Loft…
-
QualityStocksNewsBreaks – Nocera, Inc. (NASDAQ: NCRA) Enters Worldwide Joint Distribution Agreement With E-PRO
Nocera (NASDAQ: NCRA) entered into a Strategic Partnership and Joint Distribution Agreement with Taiwan-based E-PRO…
-
QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Appoints Brian Goldenberg as Chief Financial Officer
Versus Systems (NASDAQ: VS) announced the appointment of Brian Goldenberg, CPA, as Chief Financial Officer,…